Since June, 2011, Acutus Medical has pioneered a new and novel approach in the minimally invasive Dipole Density Mapping System, Generating CT/MRI Quality, Real-Time 3D Images of the Heart. Acutus Medical has concentrated its efforts on developing its technology for the treatment of an aberrant arrhythmia, atrial fibrillation (AF).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/20/13 | $28,000,000 | Series B |
Advent Life Sciences GE Ventures Index Ventures OrbiMed Advisors | undisclosed |
| 03/22/16 | $75,000,000 | Series C |
Advent Life Sciences Deerfield Management Company, L.P. GE Ventures OrbiMed Advisors Xeraya Capital | undisclosed |
